SWILEM PHARMACEUTICALS
0640.994.707 · rovalta.com · 25/09/2026
SWILEM PHARMACEUTICALS
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSWILEM PHARMACEUTICALS is a Private company with limited liability incorporated in 2015. Its main activity is: Management consultancy activities. Its registered office is in Evere.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0640.994.707
- Incorporation
- 15/10/2015
- Legal form
- Private company with limited liability
- Registered office
- Allées de Provence 54
1140 Evere · BruxellesSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 313
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 30,2 k € | -5.3% | 31,8 k € | -15.7% | 37,8 k € | +0.5% | 37,6 k € | +16.6% | 32,2 k € |
| EBITDA | 25,5 k € | +31.1% | 19,4 k € | -42.9% | 34 k € | -0.5% | 34,2 k € | +18.2% | 28,9 k € |
| Operating result | 2 k € | -12.6% | 2,3 k € | +117% | -13,8 k € | -252% | 9,1 k € | +385% | 1,9 k € |
| Net result | -7,8 k € | +4.3% | -8,1 k € | +63.6% | -22,4 k € | -1401% | 1,7 k € | +141% | -4,2 k € |
| Balance sheet | |||||||||
| Equity | -20,4 k € | -61.7% | -12,6 k € | -182% | -4,5 k € | -125% | 17,9 k € | +10.6% | 16,2 k € |
| Total assets | 293 k € | +4.7% | 279,8 k € | -9.8% | 310,3 k € | +37.5% | 225,7 k € | -24.3% | 298 k € |
| Cash | 19,3 k € | +74.7% | 11 k € | -13.0% | 12,7 k € | -65.6% | 37 k € | -59.7% | 91,7 k € |
| Debts | 313,4 k € | +7.2% | 292,4 k € | -7.1% | 314,8 k € | +51.4% | 207,9 k € | -26.3% | 281,9 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 09/07/2026 | 10/07/2025 | 24/07/2024 | 11/07/2023 | 02/08/2022 | 25/06/2021 |
| General meeting | 15/06/2026 | 23/06/2025 | 01/07/2024 | 01/06/2023 | 01/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 15/06/2026 | 09/07/2026 | French | |
| Micro model | 31/12/2024 | 23/06/2025 | 10/07/2025 | French | |
| Micro model | 31/12/2023 | 01/07/2024 | 24/07/2024 | French | |
| Micro model | 31/12/2022 | 01/06/2023 | 11/07/2023 | French | |
| Micro model | 31/12/2021 | 01/06/2022 | 02/08/2022 | French | |
| Micro model | 31/12/2020 | 01/06/2021 | 25/06/2021 | French | |
| Micro model | 31/12/2019 | 02/06/2020 | 07/08/2020 | French | |
| Micro model | 31/12/2018 | 01/06/2019 | 12/08/2019 | French | |
| Micro model | 31/12/2017 | 01/06/2018 | 12/06/2018 | French | |
| Abridged model | 31/12/2016 | 01/06/2017 | 04/07/2017 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-7,8 k €↑
- 2024Annual accounts 2024-8,1 k €↑
- 2023Annual accounts 2023-22,4 k €↓
- 2022Annual accounts 20221,7 k €↑
- 2021Annual accounts 2021-4,2 k €↓
- 2020Annual accounts 202016,1 k €↑
- 2019Annual accounts 20193,8 k €↑
- 2018Annual accounts 2018-4,4 k €↓
- 2017Annual accounts 2017-2,7 k €↓
- 2016Annual accounts 20161,3 k €
- 15/10/2015IncorporationPrivate company with limited liability